X T L Biopharmaceuticals reported -479000 in EBITDA for its fiscal quarter ending in December of 2024.


Ebitda Change Date
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
Bioline Rx USD -3488000 1.26M Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025
X T L Biopharmaceuticals -479000 19K Dec/2024